• Careers
  • Contact
Crescendo
  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisers
    • Investors
  • Humabody®
    • Overview
    • Transgenic VH Platform
    • Humabody® Therapeutics
  • Pipeline
    • Overview
    • Our Proprietary Pipeline
    • Our Assets for Partnering
    • Collaboration Programmes
  • Partnering
  • News & Media
    • PR & News
    • In the Press
    • Press Kit
    • Videos
    • Posters & Publications
  • Events
  • Menu

Crescendo Biologics Reaches First Major Milestone in Strategic Collaboration with Takeda

16 April 2018/in homepage, PR & News /by fr00fRoU

Crescendo Biologics Reaches First Major Milestone in Strategic Collaboration with Takeda

view PDF

/wp-content/uploads/2016/02/logo_crescendo.png 0 0 fr00fRoU /wp-content/uploads/2016/02/logo_crescendo.png fr00fRoU2018-04-16 09:06:262018-04-16 09:06:26Crescendo Biologics Reaches First Major Milestone in Strategic Collaboration with Takeda

Recent Posts

  • Crescendo Biologics enters pre-clinical collaboration with Orano Med to explore Targeted Alpha Therapy
  • Crescendo Biologics enters pre-clinical collaboration with Orano Med to explore Targeted Alpha Therapy
  • Unlocking the potential of PSMA as a cancer target
  • Development of a Stable Spray Dried Forumlation of an IL-17A Humabody VH Domain
  • Crescendo Biologics and Cancer Research UK sign Clinical Development Partnership to develop CB213, a novel bispecific Humabody® therapeutic

Archives

  • July 2020
  • May 2020
  • February 2020
  • January 2020
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • January 2019
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • February 2017
  • January 2017
  • November 2016
  • October 2016
  • September 2016
  • April 2016
  • February 2016
  • November 2015
  • October 2015
  • May 2015
  • March 2015
  • January 2015
  • December 2014
  • October 2014
  • April 2014
  • March 2014
  • December 2013
  • January 2013
  • October 2012
  • August 2012
  • June 2011
  • April 2011
  • January 2011
  • September 2010
  • January 2010
  • October 2009

Humabody® is a registered trademark of Crescendo Biologics Ltd.

Meditrina Building 260, Babraham Research Campus, Cambridge, CB22 3AT
© Crescendo Biologics  ·  privacy policy  · website by Instinctif Partners
CEO Peter Pack interviewed by Scrip at Bio-Europe Spring 2018 Crescendo Biologics Ltd. Raises $70 Million (€57 Million) in Series B Fin...
Scroll to top